Fifth Third Securities’s iShares Biotechnology ETF IBB Stock Holding History

Fifth Third Securities’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,654	Closed	-$216K	–	198
2022 Q1	$216K	Sell	1,654 -1,414	-46%	-$184K	0.64%	46
2021 Q4	$468K	Buy	3,068 +204	+7%	+$31.6K	0.05%	176
2021 Q3	$463K	Buy	+2,864	New	+$482K	0.06%	150

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Fifth Third Securities's IBB Position: Q2 2022 in Review

Fifth Third Securities sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 1,654 shares — an estimated $216K sold.

Fifth Third Securities first reported a position in IBB in Q3 2021 and held it in 3 quarters. The position peaked at $468K in Q4 2021. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

Fifth Third Securities reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
Fifth Third Securities sold 1,654 iShares Biotechnology ETF shares in Q2 2022, an estimated $216K.
Fifth Third Securities first reported a position in iShares Biotechnology ETF in Q3 2021 and held it in 3 quarters.
Fifth Third Securities's iShares Biotechnology ETF position peaked at $468K in Q4 2021.
858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on Fifth Third Securities's 13F filing for Q2 2022, filed 27 Jul 2022.